OmTx published 257 molecular predictions from people who have never touched this protein in a lab.
Public source
Publisher name
Public post
257 molecules are in on STAT6. that's 257 predictions from people who have never touched this protein in a lab, and we're about to find out which ones were right. valida…
Company
OmTx
decoding the language of discovery
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 51–200 employees
About OmTx
decoding the language of discovery. We are building a proprietary training set annotating the trillions of potential interactions between billions of molecules and entire proteomes. We're decentralizing access to this data and our proprietary ML models across the globe to help researchers launch discovery programs instantly.
See moreLatest activity
Latest activity from OmTx
17 signals
Research & Knowledge
OmTx submitted 257 molecules to the Om Open Pipeline Challenge for STAT6 validation.
Research & Knowledge
OmTx offers 5,000 wallet credits and $1,000 per qualified binder for submissions.
Research & Knowledge
OmTx is validating 257 molecular predictions from people who have never touched this protein in a lab.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Amgen
Amgen published results from OpenDDE reporting 66.4 percent interface success on its newest antibody antigen benchmark.
Research & Knowledge
Recludix Pharma
Recludix Pharma published findings suggesting that orthosteric SH2 domain inhibition could offer an optimal approach to targeting STAT6 with potent, highly selective inhibition and biologic-like efficacy in preclinical models.
Research & Knowledge
ScienTek
ScienTek showed that TIGRa matched or outperformed CRISPR activators on six out of nine therapeutic genes tested.
Research & Knowledge
Oxford BioDynamics Plc
Oxford BioDynamics Plc has generated over 1.5 billion datapoints and approximately 1.1 million conserved 3D genomic conformations from more than 18,000 samples across over 40 disease areas.
Research & Knowledge
Synterex